13F Holdings
中文EN

BOLD Boundless Bio, Inc.

Pharmaceutical Preparations · Nasdaq · SEC CIK 1782303 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY10.1%
TTM EPS YoY7.5%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE-64.6%
ROA-47.8%
ROIC (approx.)-76.5%
Asset turnover—

Leverage & solvency

Liabilities / assets2.9%
Debt / equity0.00x
Current ratio33.97x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.03x
Accruals ratio1.2%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31
Income statement
Revenue———
R&D expense$44.84M$55.27M$42.64M
SG&A expense$18.71M$18.00M$12.16M
Operating income-$63.55M-$73.27M-$54.80M
Income tax$0$0—
Net income-$58.20M-$65.36M-$49.43M
EBITDA-$62.30M-$72.18M-$53.84M
EPS (basic)-2.60-3.85-40.65
EPS (diluted)-2.60-3.85-40.65
Weighted avg. shares (diluted)22.36M16.98M1.22M
Balance sheet
Cash & equivalents$17.87M$27.15M$24.27M
Short-term investments$89.71M$125.53M$97.05M
Current assets$109.61M$154.39M$124.20M
PP&E, net$3.22M$4.32M$2.57M
Total assets$157.06M$206.41M$129.89M
Current liabilities$12.54M$8.13M$9.36M
Total liabilities$58.41M$55.77M$9.36M
Shareholders' equity$98.65M$150.64M-$127.08M
Shares outstanding22.41M22.30M1,248
Cash flow statement
Operating cash flow-$46.66M-$60.84M-$46.85M
Capital expenditure$546,000$2.54M$633,000
Free cash flow-$47.21M-$63.38M-$47.49M
Investing cash flow$37.80M-$26.10M-$38.26M
Financing cash flow$141,000$89.82M$97.90M
Depreciation & amortization$1.25M$1.09M$957,000
Stock-based compensation$6.12M$7.52M$3.34M

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.